Order:
  1.  46
    All Gifts Large and Small.Dana Katz, Arthur L. Caplan & Jon F. Merz - 2003 - American Journal of Bioethics 3 (3):39-46.
    Much attention has been focused in recent years on the ethical acceptability of physicians receiving gifts from drug companies. Professional guidelines recognize industry gifts as a conflict of interest and establish thresholds prohibiting the exchange of large gifts while expressly allowing for the exchange of small gifts such as pens, note pads, and coffee. Considerable evidence from the social sciences suggests that gifts of negligible value can influence the behavior of the recipient in ways the recipient does not always realize. (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   43 citations  
  2.  49
    All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift-Giving.Jon F. Merz, Arthur L. Caplan & Dana Katz - 2010 - American Journal of Bioethics 10 (10):11-17.
    Much attention has been focused in recent years on the ethical acceptability of physicians receiving gifts from drug companies. Professional guidelines recognize industry gifts as a conflict of interest and establish thresholds prohibiting the exchange of large gifts while expressly allowing for the exchange of small gifts such as pens, note pads, and coffee. Considerable evidence from the social sciences suggests that gifts of negligible value can influence the behavior of the recipient in ways the recipient does not always realize. (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   13 citations  
  3.  16
    “The Keeping is the Problem”: A Qualitative Study of IRB-Member Perspectives in Botswana on the Collection, Use, and Storage of Human Biological Samples for Research.Francis Barchi, Keikantse Matlhagela, Nicola Jones, Poloko M. Kebaabetswe & Jon F. Merz - 2015 - BMC Medical Ethics 16 (1):1-11.
    BackgroundConcurrent with efforts to establish national and regional biorepositories in Africa is widespread endorsement of ethics committees as stewards of the interests of individual donors and their communities. To date, ethics training programs for IRB members in Botswana have focused on ethical principles and international guidelines rather than on the ethical dimensions of specific medical technologies and research methodologies. Little is known about the knowledge and concerns of current and prospective IRB members in Botswana with respect to export, reuse, storage, (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  4.  11
    Fostering IRB Collaboration for Review of International Research.Francis Barchi, Megan Kasimatis Singleton & Jon F. Merz - 2014 - American Journal of Bioethics 14 (5):3-8.
    This article presents a review of the literature, summarizes current initiatives, and provides a heuristic for assessing the effectiveness of a range of institutional review board collaborative strategies that can reduce the regulatory burden of ethics review while ensuring protection of human subjects, with a particular focus on international research. Broad adoption of IRB collaborative strategies will reduce regulatory burdens posed by overlapping oversight mechanisms and has the potential to enhance human subjects protections.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  5.  36
    How Much Are Subjects Paid to Participate in Research?Jessica Latterman & Jon F. Merz - 2001 - American Journal of Bioethics 1 (2):45 – 46.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   13 citations  
  6.  37
    Improving Informed Consent: The Medium Is Not the Message.Patricia Agre, Frances A. Campbell, Barbara D. Goldman, Maria L. Boccia, Nancy Kass, Laurence B. McCullough, Jon F. Merz, Suzanne M. Miller, Jim Mintz & Bruce Rapkin - 2003 - IRB: Ethics & Human Research 25 (5):S11.
  7.  7
    SUPPORT Asked the Wrong Question.Jon F. Merz & Divya Yerramilli - 2013 - American Journal of Bioethics 13 (12):25-26.
  8.  19
    Research Misconduct Among Clinical Trial Staff.Barbara K. Redman, Thomas N. Templin & Jon F. Merz - 2006 - Science and Engineering Ethics 12 (3):481-489.
    Between 1993 and 2002, 39 clinical trial staff were investigated for scientific misconduct by the Office of Research Integrity (ORI). Analysis of ORI case records reveals practices regarding workload, training and supervision that enable misconduct. Considering the potential effects on human subjects protection, quality and reliability of data, and the trustworthiness of the clinical research enterprise, regulations or guidance on use of clinical trial staff ought to be available. Current ORI regulations do not hold investigators or institutions responsible for supervision (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  9.  29
    A Pilot Survey on the Licensing of DNA Inventions.Michelle R. Henry, Mildred K. Cho, Meredith A. Weaver & Jon F. Merz - 2003 - Journal of Law, Medicine and Ethics 31 (3):442-449.
    Intellectual property in biotechnology invention provides important incentives for research and development leading to advances in genetic tests and treatments. However, there have been numerous concerns raised regarding the negative effect patents on gene sequences and their practical applications may have on clinical research and the availability of new medical tests and procedures. One concern is that licensing policies attempting to capture for the benefit of the licensor valuable rights to downstream research results and products may increase the financial risks (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  10.  38
    Disease Genes Are Not Patentable: A Rebuttal of McGee.Jon F. Merz & Mildred K. Cho - 1998 - Cambridge Quarterly of Healthcare Ethics 7 (4):425-428.
    Dr. McGee presents a cogent argument for the patentability of the diagnosis of gene forms that are found to be associated with disease or other phenotypic manifestations. We're convinced he's wrong. An analogy will help explain why.
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  11.  5
    A Pilot Survey on the Licensing of DNA Inventions.Michelle R. Henry, Mildred K. Cho, Meredith A. Weaver & Jon F. Merz - 2003 - Journal of Law, Medicine and Ethics 31 (3):442-449.
    Intellectual property in biotechnology invention provides important incentives for research and development leading to advances in genetic tests and treatments. However, there have been numerous concerns raised regarding the negative effect patents on gene sequences and their practical applications may have on clinical research and the availability of new medical tests and procedures. One concern is that licensing policies attempting to capture for the benefit of the licensor valuable rights to downstream research results and products may increase the financial risks (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  12.  7
    A Response to Commentators on "All Gifts Large and Small".Dana Katz, Arthur L. Caplan & Jon F. Merz - 2003 - American Journal of Bioethics 3 (3):63-63.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  13.  8
    A Pilot Study of Universities' Willingness to Solicit Whistleblowers for Participation in a Study.Melissa J. Byrn, Barbara K. Redman & Jon F. Merz - 2016 - Ajob Empirical Bioethics 7 (4):260-264.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  14.  9
    Hospital Consent for Disclosure of Medical Records.Jon F. Merz, Pamela Sankar & Simon S. Yoo - 1998 - Journal of Law, Medicine and Ethics 26 (3):241-248.
    Physicians and other health care providers owe ethical and legal duties to patients to maintain the secrecy of the information learned during the course of patient care. This obligation is fulfilled by limiting access to such information to only those involved in the patient's care-that is, to those within the “circle of confidentiality.” As a general rule, providers may only disclose to others with the written prior consent of the patient. Exceptions may be “ethically and legally justified because of overriding (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  15.  6
    Hospital Consent for Disclosure of Medical Records.Jon F. Merz, Pamela Sankar & Simon S. Yoo - 1998 - Journal of Law, Medicine and Ethics 26 (3):241-248.
    Physicians and other health care providers owe ethical and legal duties to patients to maintain the secrecy of the information learned during the course of patient care. This obligation is fulfilled by limiting access to such information to only those involved in the patient's care-that is, to those within the “circle of confidentiality.” As a general rule, providers may only disclose to others with the written prior consent of the patient. Exceptions may be “ethically and legally justified because of overriding (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  16.  67
    Is Genetics Research "Minimal Risk"?Jon F. Merz - 1996 - IRB: Ethics & Human Research 18 (6):7-8.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  17.  2
    Medical Uncertainty.Jon F. Merz - 1992 - Journal of Law, Medicine and Ethics 20 (3):268-270.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  18.  8
    Medical Uncertainty (Reprise).Jon F. Merz - 1992 - Journal of Law, Medicine and Ethics 20 (3):268-270.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  19.  4
    On the Intersection of Privacy, Consent, Commerce and Genetics Research.Jon F. Merz - 2003 - In Bartha Maria Knoppers (ed.), Populations and Genetics: Legal and Socio-Ethical Perspectives. Martinus Nijhoff. pp. 257--268.
  20.  7
    Pilot Study: Does the White Coat Influence Research Participation?Jon F. Merz, Timothy R. Rebbeck, Pamela Sankar & Emma A. Meagher - 2002 - IRB: Ethics & Human Research 24 (4):6.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark